يبحث (أخبار)

EZH2 Targeted Therapy Market Research 2026: Ipsen Leads With Tazverik, Hengrui And Pfizer Advance Next-Generation EZH2 Programs - Opportunities, Approved Drug Prices, Sales, Clinical Trials Insights

science technology top

(MENAFN - GlobeNewsWire - Nasdaq) The report identifies substantial opportunities in developing EZH2-targeted therapies for cancer treatment, highlighting current clinical trials and the potential ...
2026-02-10 04:16:13